BridgePort Financial Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.68M Sell
131,024
-17
-0% -$453 1.04% 24
2025
Q4
$3.26M Sell
131,041
-278
-0.2% -$7.01K 0.88% 30
2025
Q3
$3.35M Buy
131,319
+116,927
+812% +$2.89M 0.9% 29
2025
Q2
$349K Buy
14,392
+1,680
+13% +$39.2K 0.12% 139
2025
Q1
$322K Buy
12,712
+32
+0.3% +$837 0.15% 121
2024
Q4
$331K Buy
+12,680
New +$344K 0.15% 119

Other funds holding PFE

BridgePort Financial Solutions's PFE Position: Q1 2026 in Review

BridgePort Financial Solutions reduced its Pfizer (PFE) stake by 0.01% in Q1 2026, selling an estimated $453 and leaving 131,024 shares worth $3.68M. The position accounts for 1.04% of the portfolio, ranked #24.

BridgePort Financial Solutions first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • BridgePort Financial Solutions held 131,024 shares of Pfizer worth $3.68M as of Q1 2026.
  • BridgePort Financial Solutions sold 17 Pfizer shares in Q1 2026, an estimated $453.
  • Pfizer made up 1.04% of BridgePort Financial Solutions's portfolio in Q1 2026, its #24 holding.
  • BridgePort Financial Solutions first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on BridgePort Financial Solutions's 13F filing for Q1 2026, filed 16 Apr 2026.